Examining the ınterval Between Radiation Therapy and Surgery in Trimodality Therapy: Try Tri Again

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2017 Sep 22

PMID 28932596

Authors

Sarah J Gao

Anthony W Kim

Affiliations

Soon will be listed here.

References

Koshy M, Fedewa S, Malik R, Ferguson M, Vigneswaran W, Feldman L . Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol. 2013; 8(7):915-22. DOI: 10.1097/JTO.0b013e31828f68b4. View

Gao S, Corso C, Wang E, Blasberg J, Detterbeck F, Boffa D . Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2016; 12(2):314-322. DOI: 10.1016/j.jtho.2016.09.122. View

Lingos T, Recht A, Vicini F, Abner A, Silver B, Harris J . Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991; 21(2):355-60. DOI: 10.1016/0360-3016(91)90782-y. View

Zheng Y, Jaklitsch M, Bueno R . Neoadjuvant Therapy in Non-Small Cell Lung Cancer. Surg Oncol Clin N Am. 2016; 25(3):567-84. DOI: 10.1016/j.soc.2016.02.010. View

Theise N, Henegariu O, Grove J, Jagirdar J, Kao P, Crawford J . Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol. 2002; 30(11):1333-8. DOI: 10.1016/s0301-472x(02)00931-1. View

Saha S, Kalathiya R, Davenport D, Ferraris V, Mullett T, Zwischenberger J . Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer. Oman Med J. 2014; 29(1):24-7. PMC: 3910412. DOI: 10.5001/omj.2014.06. View

Albain K, Swann R, Rusch V, Turrisi 3rd A, Shepherd F, Smith C . Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009; 374(9687):379-86. PMC: 4407808. DOI: 10.1016/S0140-6736(09)60737-6. View

Thomas M, Rube C, Hoffknecht P, Macha H, Freitag L, Linder A . Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol. 2008; 9(7):636-48. DOI: 10.1016/S1470-2045(08)70156-6. View

Groome P, Bolejack V, Crowley J, Kennedy C, Krasnik M, Sobin L . The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007; 2(8):694-705. DOI: 10.1097/JTO.0b013e31812d05d5. View

10.

Friedel G, Budach W, Dippon J, Spengler W, Eschmann S, Pfannenberg C . Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a.... J Clin Oncol. 2010; 28(6):942-8. DOI: 10.1200/JCO.2008.21.7810. View

11.

Gillaspie E, Wigle D . Management of Stage IIIA (N2) Non-Small Cell Lung Cancer. Thorac Surg Clin. 2016; 26(3):271-85. DOI: 10.1016/j.thorsurg.2016.04.001. View

12.

Burkes R, Shepherd F, Blackstein M, Goldberg M, Waters P, Patterson G . Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial. Lung Cancer. 2004; 47(1):103-9. DOI: 10.1016/j.lungcan.2004.06.004. View